Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1999 Feb;79(3-4):520–524. doi: 10.1038/sj.bjc.6690081

Peritoneal cytology in the surgical evaluation of gastric carcinoma

N Hayes 1, J Wayman 1, V Wadehra 2, D J Scott 2, S A Raimes 1, S M Griffin 1
PMCID: PMC2362407  PMID: 10027323

Abstract

Many patients undergoing surgery for gastric carcinoma will develop peritoneal metastases. A method to identify those patients at risk of peritoneal recurrence would help in the selection of patients for adjuvant therapy. Peritoneal cytology has received little attention in the West, but may prove a useful additional means of evaluating patients with gastric cancer. The aims of this study were to evaluate sampling techniques for peritoneal cytology in patients with gastric cancer, to assess the prognostic significance of free peritoneal malignant cells and to discover the effect of the operative procedure on dissemination of malignant cells. The study is based on 85 consecutive patients undergoing surgical treatment of gastric cancer and followed up for 2 years or until death. Peritoneal cytology samples were collected at laparoscopy, and at operation prior to resection by intraperitoneal lavage and serosal brushings. After resection, samples were taken by peritoneal lavage, imprint cytology of the resected specimen and post-operatively by peritoneal irrigation via a percutaneous catheter. Malignant cells were diagnosed by two independent microscopists. Preoperative peritoneal lavage yielded malignant cells in 16 out of 85 cases (19%). The yield of free malignant cells was increased by using serosal brushings (by four cases) and imprint cytology (by two cases); all of the cases had evidence of serosal penetration. One serosa-negative case exhibited positive cytology in the post-resection peritoneal specimen in which the preresection cytology specimen was negative. Survival was worse in the cytology-positive group (χ2 = 25.1; P < 0.0001). Among serosa-positive patients, survival was significantly reduced if cytology was positive, if cases yielded by brushings and imprint cytology were included (log-rank test = 8.44; 1 df, P = 0.004). In conclusion, free peritoneal malignant cells can be identified in patients with gastric cancer who have a poor prognosis; the yield can be increased with brushings and imprint cytology in addition to conventional peritoneal lavage. Evaluation of peritoneal cytology by these methods may have a role in the selection of patients with the poorest prognosis who may benefit most from adjuvant therapy. © 1999 Cancer Research Campaign

Keywords: gastric cancer, peritoneal cytology, prognosis

Full Text

The Full Text of this article is available as a PDF (72.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allum W. H., Hallissey M. T., Ward L. C., Hockey M. S. A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group. Br J Cancer. 1989 Nov;60(5):739–744. doi: 10.1038/bjc.1989.350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Allum W. H., Powell D. J., McConkey C. C., Fielding J. W. Gastric cancer: a 25-year review. Br J Surg. 1989 Jun;76(6):535–540. doi: 10.1002/bjs.1800760604. [DOI] [PubMed] [Google Scholar]
  3. Boku T., Nakane Y., Minoura T., Takada H., Yamamura M., Hioki K., Yamamoto M. Prognostic significance of serosal invasion and free intraperitoneal cancer cells in gastric cancer. Br J Surg. 1990 Apr;77(4):436–439. doi: 10.1002/bjs.1800770425. [DOI] [PubMed] [Google Scholar]
  4. Bonenkamp J. J., Songun I., Hermans J., van de Velde C. J. Prognostic value of positive cytology findings from abdominal washings in patients with gastric cancer. Br J Surg. 1996 May;83(5):672–674. doi: 10.1002/bjs.1800830526. [DOI] [PubMed] [Google Scholar]
  5. Cunliffe W. J., Sugarbaker P. H. Gastrointestinal malignancy: rationale for adjuvant therapy using early postoperative intraperitoneal chemotherapy. Br J Surg. 1989 Oct;76(10):1082–1090. doi: 10.1002/bjs.1800761030. [DOI] [PubMed] [Google Scholar]
  6. Hagiwara A., Takahashi T., Kojima O., Sawai K., Yamaguchi T., Yamane T., Taniguchi H., Kitamura K., Noguchi A., Seiki K. Prophylaxis with carbon-adsorbed mitomycin against peritoneal recurrence of gastric cancer. Lancet. 1992 Mar 14;339(8794):629–631. doi: 10.1016/0140-6736(92)90792-2. [DOI] [PubMed] [Google Scholar]
  7. Hallissey M. T., Dunn J. A., Ward L. C., Allum W. H. The second British Stomach Cancer Group trial of adjuvant radiotherapy or chemotherapy in resectable gastric cancer: five-year follow-up. Lancet. 1994 May 28;343(8909):1309–1312. doi: 10.1016/s0140-6736(94)92464-3. [DOI] [PubMed] [Google Scholar]
  8. Iitsuka Y., Kaneshima S., Tanida O., Takeuchi T., Koga S. Intraperitoneal free cancer cells and their viability in gastric cancer. Cancer. 1979 Oct;44(4):1476–1480. doi: 10.1002/1097-0142(197910)44:4<1476::aid-cncr2820440442>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  9. Kaibara N., Iitsuka Y., Kimura A., Kobayashi Y., Hirooka Y., Nishidoi H., Koga S. Relationship between area of serosal invasion and prognosis in patients with gastric carcinoma. Cancer. 1987 Jul 1;60(1):136–139. doi: 10.1002/1097-0142(19870701)60:1<136::aid-cncr2820600125>3.0.co;2-x. [DOI] [PubMed] [Google Scholar]
  10. Nakajima T., Harashima S., Hirata M., Kajitani T. Prognostic and therapeutic values of peritoneal cytology in gastric cancer. Acta Cytol. 1978 Jul-Aug;22(4):225–229. [PubMed] [Google Scholar]
  11. Soosay G. N., Griffiths M., Papadaki L., Happerfield L., Bobrow L. The differential diagnosis of epithelial-type mesothelioma from adenocarcinoma and reactive mesothelial proliferation. J Pathol. 1991 Apr;163(4):299–305. doi: 10.1002/path.1711630406. [DOI] [PubMed] [Google Scholar]
  12. Sue-Ling H. M., Johnston D., Martin I. G., Dixon M. F., Lansdown M. R., McMahon M. J., Axon A. T. Gastric cancer: a curable disease in Britain. BMJ. 1993 Sep 4;307(6904):591–596. doi: 10.1136/bmj.307.6904.591. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES